CARMEL, Ind.--(BUSINESS WIRE)--OBS Medical announced today that it has been awarded $2M from the Indiana 21st Century Research and Technology Fund. The company plans to use the Fund to accelerate development of its BioQTTM technology, an exciting innovation for pharmaceutical cardiac safety.
